Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Faillace L. A., Synder S. H., Weingartner H. 2,5-dimethoxy-4-methylamphetamine: clinical evaluation of a new hallucinogenic drug. J Nerv Ment Dis. 1970 Feb;150(2):119–126. [PubMed] [Google Scholar]
- Naranjo C., Shulgin A. T., Sargent T. Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy. Med Pharmacol Exp Int J Exp Med. 1967;17(4):359–364. doi: 10.1159/000137100. [DOI] [PubMed] [Google Scholar]
- Richards K. C., Borgstedt H. H. Near fatal reaction to ingestion of the hallucinogenic drug MDA. JAMA. 1971 Dec 20;218(12):1826–1827. [PubMed] [Google Scholar]
- SHULGIN A. T. 3-METHOXY-4,5-METHYLENEDIOXY AMPHETAMINE, A NEW PSYCHOTOMIMETIC AGENT. Nature. 1964 Mar 14;201:1120–1121. doi: 10.1038/2011120a0. [DOI] [PubMed] [Google Scholar]
- Shulgin A. T. Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines. Experientia. 1964 Jul 15;20(7):366–367. doi: 10.1007/BF02147960. [DOI] [PubMed] [Google Scholar]
- Taylor R. L., Maurer J. I., Tinklenberg J. R. Management of "bad trips" in an evolving drug scene. JAMA. 1970 Jul 20;213(3):422–425. [PubMed] [Google Scholar]
- Teitelbaum D. T. Poisoning with psychoactive drugs. Pediatr Clin North Am. 1970 Aug;17(3):557–567. doi: 10.1016/s0031-3955(16)32451-8. [DOI] [PubMed] [Google Scholar]